Direxion Daily S&P Biotech Bear 3X Shares
ETFYour view on LABD
Direxion Daily S&P Biotech Bear 3X Shares
ETFDirexionSentiment
AUM (USD)
$95.65M
Expense Ratio
1.08%
Holdings
11
Sentiment
Overview for Direxion Daily S&P Biotech Bear 3X Shares
- Fund Type
- ETF
- Fund Issuer
- Direxion
- Asset Class
- Leveraged/Inverse
- Sector
- Financial Services
- Industry
- Asset Management - Leveraged
- Inception Date
- May 28, 2015
- Domicile
- US
- Fund Type
- ETF
- Fund Issuer
- Direxion
- Asset Class
- Leveraged/Inverse
- Sector
- Financial Services
- Industry
- Asset Management - Leveraged
- Inception Date
- May 28, 2015
- Domicile
- US
- Fund Type
- ETF
- Fund Issuer
- Direxion
- Asset Class
- Leveraged/Inverse
- Sector
- Financial Services
- Industry
- Asset Management - Leveraged
- Inception Date
- May 28, 2015
- Domicile
- US
About this fund
The Direxion Daily S&P Biotech Bull and Bear 3X Shares seek daily investment results, before fees and expenses, of 300%, or 300% of the inverse (or opposite), of the performance of the S&P Biotechnology Select Industry Index. There is no guarantee the funds will achieve their sta…
LABD Stock Price
Key Facts
Leveraged/InverseExpense Ratio
1.08%
AUM
$95.65M
Fund Details
Expense Ratio
1.08%
Assets Under Management
$95.65M
NAV
$7.44 USD
Holdings
11
Average Volume
11.82M
Inception Date
May 28, 2015
Asset Class
Leveraged/Inverse
Fund Issuer
Direxion
Domicile
US
ISIN
US25461H8530
CUSIP
25461H853
NAV Currency
USD
Expense Ratio
1.08%
Assets Under Management
$95.65M
NAV
$7.44 USD
Holdings
11
Average Volume
11.82M
Inception Date
May 28, 2015
Asset Class
Leveraged/Inverse
Fund Issuer
Direxion
Domicile
US
ISIN
US25461H8530
CUSIP
25461H853
NAV Currency
USD
Latest headlines and company announcements for this company. Press releases and market coverage, newest first.
News
this company valued side by side against its closest peers. Peer-relative multiples and operating metrics, so the valuation is read in the context of its own sector rather than in isolation.